You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon beta1b

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)

Completed
Has Results
  • Multiple Sclerosis
  • Interferon beta 1a, oral doxycycline
  • Shreveport, Louisiana
    LSU Health Sciences Center Shreveport
Oct 11, 2022

Sarcoma, Kaposi, HIV Trial in Los Angeles, Chicago (Interferon beta-1b, Zidovudine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Los Angeles, California
  • +3 more
Oct 26, 2021

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

US PROmyBETAapp2.0: A Study to Learn More About Medication Usage

Completed
  • Multiple Sclerosis
  • Interferon-beta-1b (BETASERON, BAY 86-5046)
  • Whippany, New Jersey
    myBETAapp
Mar 2, 2022

Multiple Sclerosis Trial in Berlin, Potsdam (Verum arm receiving Gilenya®, Active Comparator receiving Extavia®)

Terminated
  • Multiple Sclerosis
  • Verum arm receiving Gilenya®
  • Active Comparator receiving Extavia®
  • Berlin, Germany
  • +1 more
Jul 28, 2021

COVID-19, INTERFERON, NEBULIZATION Trial in France (inhaled type I interferon, WFI water nebulization)

Recruiting
  • COVID-19
  • +2 more
  • inhaled type I interferon
  • WFI water nebulization
  • Abbeville, France
  • +6 more
Jan 3, 2022

Covid19 Trial in Hong Kong (Interferon beta-1b, Remdesivir)

Recruiting
  • Covid19
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Dec 9, 2020

Multiple Sclerosis (MS) Germany Treated With Betaferon

Completed
  • Multiple Sclerosis
  • Interferon beta-1b (Betaferon, BAY86-5046)
  • Betaconnect Autoinjector
  • Multiple Locations, Germany
    (unnamed)
Jan 15, 2021

COVID Trial in Hong Kong (Interferon Beta-1B, Hydroxychloroquine)

Completed
  • COVID
  • Hong Kong, Hong Kong
    The University of Hong Kong, Queen Mary Hospital
Jul 27, 2020

Multiple Sclerosis Trial in Cairo (Blood sample collection)

Recruiting
  • Multiple Sclerosis
  • Blood sample collection
  • Cairo, Egypt
    Nasser Institute for Research and Treatment
Feb 21, 2023

COVID-19 Trial in Tehran (Hydroxychloroquine, Lopinavir / Ritonavir, Interferon Beta-1A)

Completed
  • COVID-19
  • Tehran, Iran, Islamic Republic of
    Loghman Hakim Hospital, Shahid Beheshti University of Medical Sc
May 2, 2020

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Riyadh (Combination of Lopinavir /Ritonavir and Interferon

Completed
  • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  • Combination of Lopinavir /Ritonavir and Interferon beta-1b
  • Placebo
  • Riyadh, Saudi Arabia
  • +1 more
May 18, 2020

Novel Coronavirus Infection Trial in Hong Kong (Lopinavir/ritonavir, Ribavirin, Interferon Beta-1B)

Completed
  • Novel Coronavirus Infection
  • Hong Kong, Hong Kong
    University of Hong Kong, Queen Mary Hospital
Apr 13, 2020

Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • peginterferon beta-1a
  • +2 more
  • Amadora, Portugal
  • +14 more
Nov 23, 2020

Covid19 Trial in United States (IFN beta-1a, Dexamethasone)

Terminated
Has Results
  • Covid19
  • Aurora, Colorado
  • +3 more
Oct 13, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Healthy Subjects, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Interferon beta-1a, Peginterferon beta-1a, Placebo)

Completed
  • Healthy Subjects
  • +2 more
  • Interferon beta-1a
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Aug 16, 2021

Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)

Not yet recruiting
  • Melanoma
  • Recombinant human interferon α1b
  • +2 more
  • Xi'an, Shaanxi, China
    Air Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022

Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as

Not yet recruiting
  • Chronic Pulmonary Aspergillosis
  • Aspergillosis
  • Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
  • Antifungals as standard of care
  • (no location specified)
Dec 13, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting
Has Results
  • Metastatic Myxoid Liposarcoma
  • +15 more
  • Interferon Gamma-1b
  • +2 more
  • Palo Alto, California
  • +6 more
Aug 2, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

Advanced Malignant Solid Tumor, Hepatocellular Carcinoma Trial in Scottsdale (Laboratory Biomarker Analysis, Pharmacological

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Hepatocellular Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 6, 2021